Search for a doctor

Kelly M. Bailey, M.D., Ph.D.

  1. Oncologist
Request an Appointment

Publications

  1. Flores-Toro J, Jagu S, Smith M, Shern J, Hawkins DS, Mardis ER, Rudzinski E, Alonzo TA, Beeles T, Ramirez N, Thomas DL, Cottrell CE, Parbhoo K, Janeway KA, Leary S, Fouladi M, Oberoi S, Venkatramani R, Irwin M, Laetsch TW, Chen KS, Bailey K, Davis JL, Sullivan MB, Boja E, Lowy D, Guidry Auvil JM, Wideman B, Kibbe W, Doroshow J, Reaman GH. Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults. J Natl Cancer Inst. 2026 Feb 1; 118 (2):199-204
    View PubMed
  2. Wrenn ED, Harris JC, Apfelbaum AA, Valenti JR, Lipson PA, Walter SI, Garcia NM, Miyaki A, Chen SC, Olson JM, Price JP, Bailey KM, Lawlor ER. Autocrine TGFbeta2 enforces a transcriptionally hybrid cell state in Ewing sarcoma. Sci Adv. 2026 Jan 23; 12 (4):eady0550 Epub 2026 Jan 21
    View PubMed
  3. Mack M, Tufino AC, Jamalruddin MA, Dey S, Pan Y, Mukherjee E, Daley JD, Meade J, Aarabi M, Maurer L, Cooper J, Bernstein KA, Bailey KM. Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma. Pediatr Blood Cancer. 2026 Jan 18; e70122 [Epub ahead of print]
    View PubMed
  4. Dela Cruz FS, Stewart EA, Surdez D, Daley JD, Soragni A, Tomazou EM, Alvarez-Perez J, Feinberg TY, Amatruda JF, Ganapathi SS, Ohm JE, Heske CM, Cohen-Gogo S, Pesic D, Nash JO, Shlien A, Roundhill EA, Burchill SA, Crompton BD, Lawlor ER, Loeb DM, Delattre O, Mora J, Scotlandi K, Reed DR, Grohar PJ, Grunewald TGP, Kovar H, Bailey KM. Advancing Preclinical Biology for Ewing Sarcoma: An International Effort. Mol Cancer Ther. 2026 Jan 2; 25 (1):48-70
    View PubMed
  5. Daley JD, Whiteway SL, Heske CM, Dela Cruz FS, Whittle SB, Cohen-Gogo S, Collier AB, Gupta A, Ohm J, Clark A, Soragni A, Lawlor E, Setty B, Grohar PJ, Janeway K, Reed DR, Slotkin EK, Bailey KM. New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer. 2025 Oct; 72 (10):e31917 Epub 2025 July 24
    View PubMed
  6. Kelsey A, Alaggio R, Webster F, Bailey KM, Bisogno G, Davis JL, Dry SM, Konovalov D, Lazar AJ, O'Sullivan MJ, Rudzinski ER, Venkatramani R, Vokuhl C, Zambrano E, Cohen M, Reyes-Mugica M. Data set for reporting of paediatric rhabdomyosarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2025 Oct; 87 (4):503-513 Epub 2025 Feb 25
    View PubMed
  7. Oliva-Ramirez J, Milewski D, Banks L, Bailey K, Moding E, Lake J, Chen A, Daley J, Resch E, Kaplan R, Ladle BH, Zhang L, Chou M, Nguyen R, Dagalakis U, Al Akoum N, Sorensen P, Fletcher J, DeMatteo R, Llosa N, Pollack S. Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout Cancers. 2025.
  8. Daley JD, Mukherjee E, Ferraro D, Tufino AC, Bailey N, Bhaskar S, Periyapatna N, MacFawn I, Hartwick S, Kunning S, Hinck C, Bruno TC, Olson AC, McAllister-Lucas LM, Hinck AP, Cooper K, Bao R, Cillo AR, Bailey KM. TGFbeta inhibition during radiation therapy enhances immune cell infiltration and decreases metastases in Ewing sarcoma. Cancer Res Commun. 2025 Aug 8 Epub 2025 Aug 08
    View PubMed
  9. Gillani R, Shulman DS, DelRocco NJ, Klega K, Han R, Krailo MD, Slack JC, Tanhaemami M, Ward A, Bainer V, Ricker C, Sparks J, Bailey KM, Reed DR, DuBois SG, Leavey P, Mascarenhas L, Grohar PJ, Church AJ, Crompton BD, Janeway KA. Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children’s Oncology Group Journal of Clinical Oncology. 2025.
  10. Dietz MS, Al-Ibraheemi A, Davis JL, Hawkins CM, Craig BT, Dasgupta R, Geller DS, Shulman DS, Cohen-Gogo S, Gupta A, Whiteway SL, Slotkin EK, Heske CM, Ahmed SK, Indelicato DJ, Albert CM, Montgomery N, Sandberg JK, Grier HE, Krailo M, Isakoff MS, Rubin E, Lawlor ER, DuBois SG, Mascarenhas L, Grohar PJ, Binitie O, Reed D, Janeway K, Roberts RD, Bailey KM. Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement. J Natl Compr Canc Netw 2024 Dec 27; 23 (1)
    View PubMed
  11. Heim TE, Hankins ML, Belayneh R, Douglas N, Dinh V, Kovvur M, Boone DN, Ukani V, Bhogal S, Patel V, Moniz TMA, Bailey KM, John I, Schoedel K, Weiss KR, Watters RJ. RNA-sequencing predicts a role of androgen receptor and aldehyde dehydrogenase 1A1 in osteosarcoma lung metastases. Oncogene. 2024 Mar; 43 (14):1007-1018 Epub 2024 Feb 15
    View PubMed
  12. Helms L, Guimera AE, Janeway KA, Bailey KM. Innovations in Cancer Treatment of Children. Pediatrics. 2023 Dec 1; 152 (6)
    View PubMed
  13. Daley J, Halligan K, Howrie D, Salgado CM, Superdock A, Friehling E, Bailey KM. Successful Treatment of Patient With Ewing Sarcoma in the Setting of Inherited Cholestatic Liver Disease. J Pediatr Hematol Oncol. 2023 Jul 1; 45 (5):e621-e623 Epub 2023 Jan 12
    View PubMed
  14. Gao Y, He XY, Wu XS, Huang YH, Toneyan S, Ha T, Ipsaro JJ, Koo PK, Joshua-Tor L, Bailey KM, Egeblad M, Vakoc CR. ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation. Nat Cell Biol. 2023 Feb; 25 (2):298-308 Epub 2023 Jan 19
    View PubMed
  15. Cillo AR, Mukherjee E, Bailey NG, Onkar S, Daley J, Salgado C, Li X, Liu D, Ranganathan S, Burgess M, Sembrat J, Weiss K, Watters R, Bruno TC, Vignali DAA, Bailey KM. Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks. Clin Cancer Res. 2022 Nov 14; 28(22):4968-4982.
    View PubMed
  16. Shulman D, Whittle S, Surdez D, Bailey K, de Álava E, Yustein J, Shlien A, Hayashi M, Bishop A, Crompton B, DuBois S, Shukla N, Leavey P, Lessnick s, Kovar H, Delattre O, Grunewald T, Antonescu C, Roberts R, Toretsky J, Tirode F, Gorlick R, Janeway K, Reed D, Lawlor E, Grohar P. An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma NPJ Precision Oncology. 2022.
  17. Weiss KR, Bailey KM. A druggable rheostat for Ewing sarcoma? Clin Cancer Res. 2022.
  18. Venier RE, Grubs RE, Kessler E, Cooper KL, Bailey KM, Meade J. Evaluations of barriers to referral for cancer predisposition syndromes in pediatric oncology patients in the United States J Genet Couns. 2022.
  19. Daley J, Williams N, Salgado CM, Schultz C, Meade J, Ozolek J, Lindsey B, Bailey KM. Cutaneous Ewing Sarcoma Presenting as a Second Primary Malignancy in a Child Journal of Pediatric Hematology/Oncology. 2022.
  20. Maurer LM, Daley JD, Mukherjee E, Venier RE, Julian CM, Bailey NG, Jacobs MF, Kumar-Sinha C, Raphael H, Periyapatna N, Weiss K, Janeway KA, Mody R, Lucas PC, McAllister-Lucas LM, Bailey KM. BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma. Cancer Res Commun. 2022 Apr; 2 (4):220-232 Epub 2022 Apr 20
    View PubMed
  21. Daley JD, Olson AC, Bailey KM. Harnessing immunomodulation during DNA damage in Ewing sarcoma. Front Oncol. 2022; 12:1048705 Epub 2022 Nov 22
    View PubMed
  22. Lopez-Nunez O, Cafferata B, Santi M, Ranganathan S, Pearce T, Kulich S, Bailey K, Broniscer A, Rossi S, Zin A, Nasrallah M, Li M, Zhong Y, Alaggio R, Surrey L. The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: Experience from three pediatric institutions with review of the literature Brain Pathol.. 2021.
  23. Krook MA, Lenyo A, Wilberding M, Barker H, Dantuono M, Bailey KM, Chen H-Z, Reeser JW, Wing MR, Miya J, Samorodnitsky E, Smith A, Dao T, Martin DM, Ciombor KK, Hays J, Freud AG, Roychowdhury S. Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma Mol Cancer Ther.. 2020.
  24. McAuley JR, Bailey KM, Ekambaram P, Klei LR, Kang H, Hu D, Freeman TJ, Concel VJ, Hubel NE, Lee JL, Klei HB, Cheng J, Sekar P, Bridwell RE, Covic L, Lucas PC, McAllister-Lucas LM. MALT1 is a critical mediator of PAR1-driven NF-kappaB activation and metastasis in multiple tumor types. Oncogene. 2019 Dec; 38 (49):7384-7398 Epub 2019 Aug 16
    View PubMed
  25. Venier RE, Maurer LM, Kessler EM, Ranganathan S, McGough RL, Weiss KR, Malek MM, Meade J, Tersak JM, Bailey KM. A germline BARD1 mutation in a patient with Ewing sarcoma: implications for familial testing and counseling Pediatr Blood Cancer. 2019.
  26. Bailey KM, Julian CM, Klinghoffer AN, Bernard H, Lucas PC, McAllister-Lucas LM. EWS-FLI1 low Ewing sarcoma cells demonstrate decreased susceptibility to T-cell-mediated tumor cell apoptosis. Oncotarget. 2019 May 21; 10 (36):3385-3399
    View PubMed
  27. Hawkins AG, Julian CM, Konzen S, Lawlor ER, Bailey KM. Microenvironmental factors drive tenascin C and Src cooperation to promote invadopodia formation in Ewing sarcoma Neoplasia. 2019.
  28. Bailey K, Cost C, Davis I, Glade-Bender J, Grohar P, Houghton P, Isakoff M, Stewart E, Laack N, Yustein J, Reed D, Janeway K, Gorlick R, Lessnick S, DuBois S, Hingorani P. Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children's Oncology Group (COG) New Agents for Ewing Sarcoma Task Force. F1000Res. 2019; 8 Epub 2019 Apr 15
    View PubMed
  29. Bailey KM, Jacobs MF, Anderson B, Rabah R, Wu YM, Else T and Mody R. DICER1 Mutations in the era of expanding integrative clinical sequencing in pediatric oncology JCO Precision Oncology. 2019. Epub 2048 Jan 01.
  30. Bailey KM. Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma Oncotarget. 2018.
  31. Bailey KM, Durham AB, Zhao L, Fullen D, Geiger J, Bradford C, Opipari V, Johnson T, Mody R. Pediatric melanoma and aggressive Spitz tumors: a retrospective diagnostic, exposure and outcome analysis Translational Pediatrics. 2018.
  32. Klei LR, Hu D, Panek R, Alfano D, Bridwell R, Bailey K, Oravecz-Wilson K, Concel V, Van M, Delekta P, Gu S, Watkins S, Ting A, Gough P, Foley K, Bertin J, McAllister-Lucas L, Lucas PC. MALT1 protease activation triggers acute disruption of endothelial barrier integrity via CYLD cleavage. Cell Reports. 2016; 17(1):221-232.
    View PubMed
  33. Pedersen EA, Menon R, Bailey KM, Thomas DG, Van Noord RA, Tran J, Wang H, Q PP, Hoering A, Fearon ER, Chugh R, Lawlor ER. Activation of Wnt/Beta-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cel States Cancer Research. 2016.
  34. Bailey KM, Airik M, Krook MA, Pedersen EA, Lawlor ER. Micro-Environmental Stress Induces Src-Dependent Activation of Invadopodia and Cell Migration in Ewing Sarcoma Neoplasia. 2016.
  35. Bailey KM, Castle VP, Hummel JM, Piert M, Moyer J, McAllister-Lucas LM. Thalidomide therapy for aggressive histiocytic lesions in the pediatric population. J Pediatr Hematol Oncol. 2012 Aug; 34 (6):480-3
    View PubMed
  36. Shrader CD, Bailey KM, Konat GW, Cilento EV, Reilly FD. Insulin Enhances Proliferation and Viability of Human Umbilical Vein Endothelial Cells Arch Dermatol Res. 2008.
  37. Bailey KM, Liu J. Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase. J Biol Chem. 2008 May 16; 283(20):13714-24. Epub 2008 Mar 10.
    View PubMed
PST-20595745